「fo」の検索結果
124件：116～120件目を表示
-
お知らせ | 千寿製薬株式会社
August 20, 2026 Senju initiated Phase III Clinical Trials in Japan for "SJP-0049" for the treatment of Allergic Conjunctivitis（PDF） June 1, 2026 Launch of Distribution of 3in1Smart and SPM-7...
http://www.senju.co.jp/english/news/ -
お知らせ | 千寿製薬株式会社
August 20, 2026 Senju initiated Phase III Clinical Trials in Japan for "SJP-0049" for the treatment of Allergic Conjunctivitis（PDF） June 1, 2026 Launch of Distribution of 3in1Smart and SPM-7...
https://www.senju.co.jp/english/news/ -
Milestones in Our History | About Senju | SENJU Pharmaceutical
ished the company in Tennoji-ku, Osaka with start-up capital of 195,000 yen. July Injection Product for Neutropenia, "PANILTIN", sales launched 1949 February Reishin Tanimura became the Pres...
https://www.senju.co.jp/english/about/history.html -
Product Development Policy | Research & Development | SENJU Pharmaceutica
ehold” or QOV (Quality of Vision) of patients worldwide. We launched senile cataract drugs in 1958, followed by a series of other products including antimicrobial ophthalmic solutions, non-steroidal a...
http://www.senju.co.jp/english/rd/policy/ -
Research and Development System | Research & Development | SENJU Pharmaceutica
All things in nature have a reason for being.Today’s common sense may not be common sense tomorrow. At Senju Pharmaceutical, we are dedicated not only to our original R&D initiatives but also to R...
http://www.senju.co.jp/english/rd/about/